Alveolar echinococcosis is caused by the metacestode stage of the fox tapeworm Echinococcus multilocularis. Current chemotherapeutical options for the treatment of echinococcosis are not satisfactory, and novel drugs and/or other potential means of therapy are needed. E. multilocularis metacestodes are characterized by almost potentially unlimited growth, and also display other features of cancerous tumours. In this study, we exposed metacestodes that were generated in vitro to 50-100 Gy ionizing irradiation, and subsequently investigated the short-term (10-12 days post-treatment) and long-term (14 weeks post-treatment) effects. We found, that in the short-term, no release of alkaline phosphatase (EmAP) activity as a measure for potentially induced damage and loss of viability could be detected, and that the protein expression pattern and protease activities in vesicle fluids and medium supernatants did not alter dramatically following irradiation. However, irradiation was associated with distinct morphological and ultrastructural alterations in the tissue of metacestodes, affecting most notably cell-cell contacts, mitochondrial shape, glycogen-storage cells and lipid droplet formation. These could be detected already at 10 days following treatment and remained as such also in the long-term. In addition, as determined after 14 weeks of culture, irradiation affected the proliferation and the growth of E. multilocularis metacestodes. Thus, we demonstrate that radiotherapy does not have a clear-cut parasitocidal effect, but can lead to metabolic impairment of E. multilocularis metacestodes, as reflected by the distinct morphological and structural alterations induced by irradiation treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2010.07.006DOI Listing

Publication Analysis

Top Keywords

multilocularis metacestodes
12
echinococcus multilocularis
8
distinct morphological
8
metacestodes
6
irradiation
5
multilocularis impact
4
impact ionizing
4
ionizing radiation
4
radiation metacestodes
4
metacestodes alveolar
4

Similar Publications

Echinococcus multilocularis delta/notch signalling components are expressed in post-mitotic cells.

Parasitol Res

December 2024

Institute of Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Strasse 2, 97080, Würzburg, Germany.

Pluripotent somatic stem cells are the drivers of unlimited growth of Echinococcus multilocularis metacestode tissue within the organs of the intermediate host. To understand the dynamics of parasite proliferation within the host, it is therefore important to delineate basic mechanisms of Echinococcus stem cell maintenance and differentiation. We herein undertake the first step towards characterizing the role of an evolutionarily old metazoan cell-cell communication system, delta/notch signalling, in Echinococcus cell fate decisions.

View Article and Find Full Text PDF

Drug repurposing for hard-to-treat human alveolar echinococcosis: pyronaridine and beyond.

Parasitology

November 2024

State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

Article Synopsis
  • Human alveolar echinococcosis is a challenging parasitic disease that is hard to treat and often untreated, leading to high healthcare costs.
  • Current treatment relies on albendazole, which isn't fully effective and can have serious side effects, highlighting the need for better options.
  • Pyronaridine, an antimalarial drug, has shown promising results in mouse models for treating the disease, significantly reducing parasite size and counts compared to albendazole, and could serve as an alternative therapy, while another compound, pirenzepine, also shows potential for further research.
View Article and Find Full Text PDF

Induced hepatocyte-like cells derived from adipose-derived stem cells alleviates liver injury in mice infected with Echinococcus Multilocularis.

Sci Rep

November 2024

State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

Article Synopsis
  • - This study explores the potential of using adipose-derived stem cells (ADSCs) to create induced hepatocyte-like cells (iHEPs) for treating liver diseases caused by Echinococcus multilocularis.
  • - After generating iHEPs through a three-step process, they were transplanted into mice infected with the parasite, and their effectiveness was evaluated through various histological and liver function tests.
  • - The findings indicated that iHEPs not only improved liver function and repaired liver damage but also activated important signaling pathways, suggesting they could be a promising treatment for severe liver conditions like hepatic alveolar echinococcosis.
View Article and Find Full Text PDF

Chemotherapy for the treatment of alveolar echinococcosis: Where are we?

Parasite

September 2024

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.

Article Synopsis
  • Alveolar echinococcosis (AE) is a serious liver disease caused by a parasite called Echinococcus multilocularis.
  • The main treatment involves using certain medications called benzimidazoles, which can help but may not work if treatment is stopped, and can also hurt the liver.
  • There are other potential treatments, but they often have side effects or are not proven to work well, so researchers are looking for better solutions.
View Article and Find Full Text PDF

Echinococcosis, one of the most serious and life-threatening parasitic forms of zoonosis worldwide, is caused by the larvae of () and (). Various drugs are being applied clinically to treat zoonosis; however, their therapeutic efficacy remains a great challenge, especially with albendazole as the preferred drug of choice. Receptor tyrosine kinase (RTK) signaling controls normal cellular proliferation, differentiation, and metabolism in humans and mammals, which are intermediate hosts of and .

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!